Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.850
-0.010-0.21%
Volume:95.91M
Turnover:469.08M
Market Cap:55.99B
PE:9.14
High:5.000
Open:4.850
Low:4.810
Close:4.860
Loading ...

CSPC Pharmaceutical - Got Approval From Nmpa China

THOMSON REUTERS
·
25 Oct 2024

CSPC Pharmaceutical - First Mrna-Lnp-Based CAR-T Cell Injection Obtains Further Clinical Trial Approval for New Indication

THOMSON REUTERS
·
25 Oct 2024

CSPC Innovation Pharmaceutical's Q3 Profit Plunges 98%

MT Newswires Live
·
23 Oct 2024

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$8.46 From HK$9.29, Keeps at Buy

MT Newswires Live
·
22 Oct 2024

Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly

Simply Wall St.
·
16 Oct 2024

Stock Track | CSPC PHARMA Plunges 8% as Lack of Stimulus Details Dents Hong Kong Market

Stock Track
·
14 Oct 2024

Hong Kong Stocks Fall on Uncertainty in Further Stimulus; Pharma Firms Lead Decline

MT Newswires Live
·
14 Oct 2024

CSPC Pharmaceutical Gets US FDA Fast Track Designation for Lung Cancer Drug

MT Newswires Live
·
08 Oct 2024

CSPC Pharmaceutical Gets China Marketing Nod for Urticaria Treatment

MT Newswires Live
·
08 Oct 2024

BRIEF-CSPC Pharmaceutical Says Omalizumab For Injection Obtains Marketing Approval From NMPA

Reuters
·
08 Oct 2024

CSPC Pharmaceutical - Omalizumab for Injection Obtains Marketing Approval Granted by Nmpa

THOMSON REUTERS
·
08 Oct 2024

BRIEF-CSPC Pharmaceutical Says Cpo301 Receives Fast Track Designation From The U.S. FDA

Reuters
·
08 Oct 2024

Voluntary Announcement - Cpo301 Receives Fast Track Designation From the US FDA

THOMSON REUTERS
·
08 Oct 2024

CSPC Pharmaceutical Set to Benefit From Exclusive Licensing Agreement With AstraZeneca -- Market Talk

Dow Jones
·
08 Oct 2024

Stock Track | CSPC Pharma Soars on Billion-Dollar Licensing Deal with AstraZeneca

Stock Track
·
08 Oct 2024

Greater China Stocks Close Mixed; Shanghai Leads Gainers

Dow Jones
·
08 Oct 2024